nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—RARB—cervical cancer	0.801	1	CbGaD
Acitretin—Lung neoplasm malignant—Topotecan—cervical cancer	0.00519	0.148	CcSEcCtD
Acitretin—CYP26A1—decidua—cervical cancer	0.00454	0.0604	CbGeAlD
Acitretin—CYP26A1—endometrium—cervical cancer	0.00431	0.0574	CbGeAlD
Acitretin—RBP1—Retinoic acid receptors-mediated signaling—RARB—cervical cancer	0.00412	0.0504	CbGpPWpGaD
Acitretin—CYP26A1—female reproductive system—cervical cancer	0.00357	0.0475	CbGeAlD
Acitretin—RARG—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.00312	0.0382	CbGpPWpGaD
Acitretin—RBP1—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.00309	0.0378	CbGpPWpGaD
Acitretin—CYP26A1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00304	0.0372	CbGpPWpGaD
Acitretin—Isotretinoin—RARB—cervical cancer	0.00302	0.418	CrCbGaD
Acitretin—RBP1—epithelium—cervical cancer	0.00287	0.0382	CbGeAlD
Acitretin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.00285	0.0349	CbGpPWpGaD
Acitretin—RBP1—uterine cervix—cervical cancer	0.00285	0.0379	CbGeAlD
Acitretin—RARG—Retinoic acid receptors-mediated signaling—RARB—cervical cancer	0.00278	0.0341	CbGpPWpGaD
Acitretin—RXRA—renal system—cervical cancer	0.00274	0.0365	CbGeAlD
Acitretin—RBP1—decidua—cervical cancer	0.00271	0.0361	CbGeAlD
Acitretin—RARA—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.00268	0.0328	CbGpPWpGaD
Acitretin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.00268	0.0328	CbGpPWpGaD
Acitretin—RBP1—renal system—cervical cancer	0.00266	0.0354	CbGeAlD
Acitretin—Bullous eruption—Topotecan—cervical cancer	0.00264	0.0751	CcSEcCtD
Acitretin—RXRG—Retinoic acid receptors-mediated signaling—RARB—cervical cancer	0.00255	0.0312	CbGpPWpGaD
Acitretin—CYP26A1—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.00252	0.0308	CbGpPWpGaD
Acitretin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00252	0.0308	CbGpPWpGaD
Acitretin—Alitretinoin—RARB—cervical cancer	0.00246	0.341	CrCbGaD
Acitretin—RXRB—Retinoic acid receptors-mediated signaling—RARB—cervical cancer	0.00239	0.0293	CbGpPWpGaD
Acitretin—RARA—Retinoic acid receptors-mediated signaling—RARB—cervical cancer	0.00239	0.0293	CbGpPWpGaD
Acitretin—RBP1—uterus—cervical cancer	0.00237	0.0316	CbGeAlD
Acitretin—RXRB—decidua—cervical cancer	0.00231	0.0307	CbGeAlD
Acitretin—RARG—Nuclear Receptors—RARB—cervical cancer	0.0023	0.0282	CbGpPWpGaD
Acitretin—RXRA—female reproductive system—cervical cancer	0.0022	0.0292	CbGeAlD
Acitretin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00217	0.0265	CbGpPWpGaD
Acitretin—RBP1—female reproductive system—cervical cancer	0.00213	0.0284	CbGeAlD
Acitretin—RXRG—Nuclear Receptors—RARB—cervical cancer	0.00211	0.0258	CbGpPWpGaD
Acitretin—RARG—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.00209	0.0255	CbGpPWpGaD
Acitretin—RARG—decidua—cervical cancer	0.00205	0.0272	CbGeAlD
Acitretin—RXRA—female gonad—cervical cancer	0.002	0.0266	CbGeAlD
Acitretin—RXRB—Nuclear Receptors—RARB—cervical cancer	0.00198	0.0242	CbGpPWpGaD
Acitretin—RARA—Nuclear Receptors—RARB—cervical cancer	0.00198	0.0242	CbGpPWpGaD
Acitretin—RARB—female reproductive system—cervical cancer	0.00197	0.0263	CbGeAlD
Acitretin—RBP1—female gonad—cervical cancer	0.00194	0.0258	CbGeAlD
Acitretin—RBP1—vagina—cervical cancer	0.00193	0.0257	CbGeAlD
Acitretin—RARA—decidua—cervical cancer	0.00192	0.0256	CbGeAlD
Acitretin—RXRG—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.00191	0.0234	CbGpPWpGaD
Acitretin—RARA—renal system—cervical cancer	0.00189	0.0251	CbGeAlD
Acitretin—RARG—mammalian vulva—cervical cancer	0.00188	0.025	CbGeAlD
Acitretin—RARA—endometrium—cervical cancer	0.00183	0.0243	CbGeAlD
Acitretin—RARG—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00182	0.0223	CbGpPWpGaD
Acitretin—RARB—female gonad—cervical cancer	0.0018	0.0239	CbGeAlD
Acitretin—RXRB—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.00179	0.022	CbGpPWpGaD
Acitretin—RARA—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.00179	0.022	CbGpPWpGaD
Acitretin—RARG—uterus—cervical cancer	0.00179	0.0238	CbGeAlD
Acitretin—RARB—vagina—cervical cancer	0.00178	0.0237	CbGeAlD
Acitretin—Tretinoin—RARB—cervical cancer	0.00173	0.24	CrCbGaD
Acitretin—Febrile neutropenia—Topotecan—cervical cancer	0.00173	0.0493	CcSEcCtD
Acitretin—RARA—uterus—cervical cancer	0.00168	0.0224	CbGeAlD
Acitretin—RXRG—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00166	0.0204	CbGpPWpGaD
Acitretin—RXRB—female gonad—cervical cancer	0.00165	0.022	CbGeAlD
Acitretin—RXRB—vagina—cervical cancer	0.00164	0.0218	CbGeAlD
Acitretin—RARG—female reproductive system—cervical cancer	0.00161	0.0214	CbGeAlD
Acitretin—RXRB—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00157	0.0192	CbGpPWpGaD
Acitretin—RARA—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00157	0.0192	CbGpPWpGaD
Acitretin—RARA—female reproductive system—cervical cancer	0.00151	0.0201	CbGeAlD
Acitretin—RARG—female gonad—cervical cancer	0.00146	0.0195	CbGeAlD
Acitretin—RARG—vagina—cervical cancer	0.00146	0.0194	CbGeAlD
Acitretin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.0014	0.0171	CbGpPWpGaD
Acitretin—RARA—female gonad—cervical cancer	0.00138	0.0183	CbGeAlD
Acitretin—Rash erythematous—Topotecan—cervical cancer	0.00136	0.0388	CcSEcCtD
Acitretin—Rigors—Topotecan—cervical cancer	0.00128	0.0364	CcSEcCtD
Acitretin—RBP1—lymph node—cervical cancer	0.00125	0.0166	CbGeAlD
Acitretin—RXRA—Retinoic acid receptors-mediated signaling—RARB—cervical cancer	0.00125	0.0153	CbGpPWpGaD
Acitretin—RARB—lymph node—cervical cancer	0.00115	0.0154	CbGeAlD
Acitretin—Bone pain—Topotecan—cervical cancer	0.00109	0.031	CcSEcCtD
Acitretin—RXRA—Nuclear Receptors—RARB—cervical cancer	0.00103	0.0126	CbGpPWpGaD
Acitretin—RARG—lymph node—cervical cancer	0.000942	0.0125	CbGeAlD
Acitretin—RXRA—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.000935	0.0114	CbGpPWpGaD
Acitretin—Ear pain—Topotecan—cervical cancer	0.000887	0.0253	CcSEcCtD
Acitretin—RARA—lymph node—cervical cancer	0.000886	0.0118	CbGeAlD
Acitretin—RXRA—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.000816	0.00999	CbGpPWpGaD
Acitretin—Dermatitis bullous—Topotecan—cervical cancer	0.000791	0.0225	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Topotecan—cervical cancer	0.000667	0.019	CcSEcCtD
Acitretin—Pancytopenia—Topotecan—cervical cancer	0.000621	0.0177	CcSEcCtD
Acitretin—Weight increased—Topotecan—cervical cancer	0.000595	0.0169	CcSEcCtD
Acitretin—Neuropathy peripheral—Topotecan—cervical cancer	0.000571	0.0163	CcSEcCtD
Acitretin—Stomatitis—Topotecan—cervical cancer	0.000568	0.0162	CcSEcCtD
Acitretin—Epistaxis—Topotecan—cervical cancer	0.00055	0.0157	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000544	0.00666	CbGpPWpGaD
Acitretin—Haemoglobin—Topotecan—cervical cancer	0.000526	0.015	CcSEcCtD
Acitretin—Rhinitis—Topotecan—cervical cancer	0.000525	0.0149	CcSEcCtD
Acitretin—Haemorrhage—Topotecan—cervical cancer	0.000523	0.0149	CcSEcCtD
Acitretin—Hypoaesthesia—Topotecan—cervical cancer	0.000521	0.0148	CcSEcCtD
Acitretin—Pharyngitis—Topotecan—cervical cancer	0.000519	0.0148	CcSEcCtD
Acitretin—ALB—lymph node—cervical cancer	0.000499	0.00664	CbGeAlD
Acitretin—Angiopathy—Topotecan—cervical cancer	0.000475	0.0135	CcSEcCtD
Acitretin—Immune system disorder—Topotecan—cervical cancer	0.000473	0.0135	CcSEcCtD
Acitretin—Chills—Topotecan—cervical cancer	0.00047	0.0134	CcSEcCtD
Acitretin—Alopecia—Topotecan—cervical cancer	0.000462	0.0132	CcSEcCtD
Acitretin—Back pain—Topotecan—cervical cancer	0.000441	0.0126	CcSEcCtD
Acitretin—Muscle spasms—Topotecan—cervical cancer	0.000438	0.0125	CcSEcCtD
Acitretin—Ill-defined disorder—Topotecan—cervical cancer	0.000423	0.012	CcSEcCtD
Acitretin—Angioedema—Topotecan—cervical cancer	0.000416	0.0119	CcSEcCtD
Acitretin—Malaise—Topotecan—cervical cancer	0.000411	0.0117	CcSEcCtD
Acitretin—Cough—Topotecan—cervical cancer	0.000397	0.0113	CcSEcCtD
Acitretin—RXRG—a6b1 and a6b4 Integrin signaling—EGFR—cervical cancer	0.000397	0.00486	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—INSM1—cervical cancer	0.000392	0.0048	CbGpPWpGaD
Acitretin—Myalgia—Topotecan—cervical cancer	0.000388	0.011	CcSEcCtD
Acitretin—Chest pain—Topotecan—cervical cancer	0.000388	0.011	CcSEcCtD
Acitretin—Arthralgia—Topotecan—cervical cancer	0.000388	0.011	CcSEcCtD
Acitretin—Discomfort—Topotecan—cervical cancer	0.000383	0.0109	CcSEcCtD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—cervical cancer	0.000373	0.00457	CbGpPWpGaD
Acitretin—Infection—Topotecan—cervical cancer	0.000369	0.0105	CcSEcCtD
Acitretin—Skin disorder—Topotecan—cervical cancer	0.000361	0.0103	CcSEcCtD
Acitretin—Hyperhidrosis—Topotecan—cervical cancer	0.000359	0.0102	CcSEcCtD
Acitretin—Anorexia—Topotecan—cervical cancer	0.000354	0.0101	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Topotecan—cervical cancer	0.000339	0.00965	CcSEcCtD
Acitretin—Paraesthesia—Topotecan—cervical cancer	0.000334	0.00951	CcSEcCtD
Acitretin—Dyspepsia—Topotecan—cervical cancer	0.000327	0.00932	CcSEcCtD
Acitretin—Decreased appetite—Topotecan—cervical cancer	0.000323	0.00921	CcSEcCtD
Acitretin—Gastrointestinal disorder—Topotecan—cervical cancer	0.000321	0.00914	CcSEcCtD
Acitretin—Fatigue—Topotecan—cervical cancer	0.000321	0.00913	CcSEcCtD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	0.000319	0.0039	CbGpPWpGaD
Acitretin—Pain—Topotecan—cervical cancer	0.000318	0.00906	CcSEcCtD
Acitretin—Constipation—Topotecan—cervical cancer	0.000318	0.00906	CcSEcCtD
Acitretin—RARG—Generic Transcription Pathway—RARB—cervical cancer	0.000314	0.00385	CbGpPWpGaD
Acitretin—Feeling abnormal—Topotecan—cervical cancer	0.000306	0.00873	CcSEcCtD
Acitretin—Gastrointestinal pain—Topotecan—cervical cancer	0.000304	0.00866	CcSEcCtD
Acitretin—Urticaria—Topotecan—cervical cancer	0.000295	0.00841	CcSEcCtD
Acitretin—Abdominal pain—Topotecan—cervical cancer	0.000294	0.00837	CcSEcCtD
Acitretin—Body temperature increased—Topotecan—cervical cancer	0.000294	0.00837	CcSEcCtD
Acitretin—RXRG—Generic Transcription Pathway—RARB—cervical cancer	0.000288	0.00352	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000284	0.00347	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—CTNNB1—cervical cancer	0.000283	0.00347	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.000277	0.00339	CbGpPWpGaD
Acitretin—Hypersensitivity—Topotecan—cervical cancer	0.000274	0.0078	CcSEcCtD
Acitretin—RARA—Generic Transcription Pathway—RARB—cervical cancer	0.00027	0.00331	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—RARB—cervical cancer	0.00027	0.00331	CbGpPWpGaD
Acitretin—Asthenia—Topotecan—cervical cancer	0.000267	0.0076	CcSEcCtD
Acitretin—Pruritus—Topotecan—cervical cancer	0.000263	0.00749	CcSEcCtD
Acitretin—RBP1—Disease—WNT2—cervical cancer	0.000259	0.00317	CbGpPWpGaD
Acitretin—Diarrhoea—Topotecan—cervical cancer	0.000254	0.00725	CcSEcCtD
Acitretin—CYP26A1—Adipogenesis—STAT3—cervical cancer	0.000247	0.00302	CbGpPWpGaD
Acitretin—Dizziness—Topotecan—cervical cancer	0.000246	0.007	CcSEcCtD
Acitretin—ALB—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.000242	0.00297	CbGpPWpGaD
Acitretin—Vomiting—Topotecan—cervical cancer	0.000236	0.00673	CcSEcCtD
Acitretin—Rash—Topotecan—cervical cancer	0.000234	0.00668	CcSEcCtD
Acitretin—Dermatitis—Topotecan—cervical cancer	0.000234	0.00667	CcSEcCtD
Acitretin—Headache—Topotecan—cervical cancer	0.000233	0.00663	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—TAAR6—cervical cancer	0.000232	0.00285	CbGpPWpGaD
Acitretin—Nausea—Topotecan—cervical cancer	0.000221	0.00629	CcSEcCtD
Acitretin—RXRG—Adipogenesis—CTNNB1—cervical cancer	0.000215	0.00263	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000212	0.0026	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000208	0.00255	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000203	0.00249	CbGpPWpGaD
Acitretin—RARA—Adipogenesis—CTNNB1—cervical cancer	0.000202	0.00247	CbGpPWpGaD
Acitretin—RBP1—Disease—WNT5A—cervical cancer	0.000196	0.0024	CbGpPWpGaD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—cervical cancer	0.000195	0.00238	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000191	0.00233	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—STAT3—cervical cancer	0.000187	0.00229	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000187	0.00229	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—WNT2—cervical cancer	0.000181	0.00222	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000179	0.00219	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000179	0.00219	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—MTHFR—cervical cancer	0.000178	0.00217	CbGpPWpGaD
Acitretin—RARA—Adipogenesis—STAT3—cervical cancer	0.000176	0.00215	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—CA9—cervical cancer	0.000167	0.00205	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.00016	0.00196	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—AKAP13—cervical cancer	0.000159	0.00195	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000155	0.00189	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000154	0.00188	CbGpPWpGaD
Acitretin—RARG—Gene Expression—RARB—cervical cancer	0.000151	0.00185	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000148	0.00182	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—MTHFR—cervical cancer	0.000144	0.00177	CbGpPWpGaD
Acitretin—ALB—Hemostasis—GP6—cervical cancer	0.000143	0.00175	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SERPIND1—cervical cancer	0.000143	0.00175	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—RARB—cervical cancer	0.000141	0.00173	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—RARB—cervical cancer	0.000138	0.00169	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—WNT5A—cervical cancer	0.000138	0.00168	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—RARB—cervical cancer	0.00013	0.00159	CbGpPWpGaD
Acitretin—RARA—Gene Expression—RARB—cervical cancer	0.00013	0.00159	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000129	0.00158	CbGpPWpGaD
Acitretin—ALB—Hemostasis—GP5—cervical cancer	0.000125	0.00153	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000123	0.0015	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000118	0.00144	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000117	0.00144	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000116	0.00142	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—MTHFR—cervical cancer	0.000115	0.00141	CbGpPWpGaD
Acitretin—RBP1—Disease—HES1—cervical cancer	0.000113	0.00138	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000111	0.00136	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000111	0.00136	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000106	0.0013	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—CTNNB1—cervical cancer	0.000105	0.00129	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000103	0.00126	CbGpPWpGaD
Acitretin—RARG—Gene Expression—NOTCH2—cervical cancer	0.0001	0.00123	CbGpPWpGaD
Acitretin—RBP1—Disease—MTHFR—cervical cancer	9.93e-05	0.00122	CbGpPWpGaD
Acitretin—RBP1—Disease—TERT—cervical cancer	9.9e-05	0.00121	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	9.86e-05	0.00121	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NOTCH2—cervical cancer	9.65e-05	0.00118	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—NOTCH2—cervical cancer	9.33e-05	0.00114	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—NOTCH2—cervical cancer	9.17e-05	0.00112	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—STAT3—cervical cancer	9.16e-05	0.00112	CbGpPWpGaD
Acitretin—RBP1—Disease—FGFR3—cervical cancer	9.09e-05	0.00111	CbGpPWpGaD
Acitretin—RARB—Gene Expression—NOTCH2—cervical cancer	8.99e-05	0.0011	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—NOTCH2—cervical cancer	8.62e-05	0.00106	CbGpPWpGaD
Acitretin—RARA—Gene Expression—NOTCH2—cervical cancer	8.62e-05	0.00106	CbGpPWpGaD
Acitretin—RBP1—Disease—NOTCH1—cervical cancer	8.53e-05	0.00104	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	8.02e-05	0.000981	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HES1—cervical cancer	7.91e-05	0.000969	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	7.73e-05	0.000946	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—HES1—cervical cancer	7.2e-05	0.000882	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TERT—cervical cancer	6.93e-05	0.000849	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—RARB—cervical cancer	6.78e-05	0.000831	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—MTHFR—cervical cancer	6.78e-05	0.00083	CbGpPWpGaD
Acitretin—RBP1—Disease—MTOR—cervical cancer	6.39e-05	0.000783	CbGpPWpGaD
Acitretin—RBP1—Disease—CD4—cervical cancer	6.38e-05	0.000781	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—FGFR3—cervical cancer	6.36e-05	0.000779	CbGpPWpGaD
Acitretin—RARG—Gene Expression—NOTCH1—cervical cancer	6.21e-05	0.00076	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CA9—cervical cancer	6.2e-05	0.00076	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	6.12e-05	0.000749	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NOTCH1—cervical cancer	5.97e-05	0.000731	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—NOTCH1—cervical cancer	5.78e-05	0.000707	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—NOTCH1—cervical cancer	5.68e-05	0.000695	CbGpPWpGaD
Acitretin—RBP1—Disease—CTNNB1—cervical cancer	5.67e-05	0.000694	CbGpPWpGaD
Acitretin—RARB—Gene Expression—NOTCH1—cervical cancer	5.57e-05	0.000682	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TP53—cervical cancer	5.49e-05	0.000672	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NOTCH1—cervical cancer	5.44e-05	0.000666	CbGpPWpGaD
Acitretin—RARA—Gene Expression—NOTCH1—cervical cancer	5.34e-05	0.000653	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—NOTCH1—cervical cancer	5.34e-05	0.000653	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	5.14e-05	0.000629	CbGpPWpGaD
Acitretin—RBP1—Disease—STAT3—cervical cancer	4.94e-05	0.000605	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NOTCH2—cervical cancer	4.49e-05	0.00055	CbGpPWpGaD
Acitretin—RBP1—Disease—EGFR—cervical cancer	4.49e-05	0.00055	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MTOR—cervical cancer	4.48e-05	0.000548	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CASP3—cervical cancer	4.12e-05	0.000504	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CTNNB1—cervical cancer	3.97e-05	0.000486	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CTNNB1—cervical cancer	3.61e-05	0.000442	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—STAT3—cervical cancer	3.46e-05	0.000424	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—STAT3—cervical cancer	3.15e-05	0.000386	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EGFR—cervical cancer	3.14e-05	0.000385	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EGFR—cervical cancer	2.86e-05	0.00035	CbGpPWpGaD
Acitretin—ALB—Metabolism—CA9—cervical cancer	2.83e-05	0.000346	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NOTCH1—cervical cancer	2.78e-05	0.000341	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—cervical cancer	2.64e-05	0.000323	CbGpPWpGaD
Acitretin—RXRA—Metabolism—MTHFR—cervical cancer	2.52e-05	0.000308	CbGpPWpGaD
Acitretin—ALB—Metabolism—MTHFR—cervical cancer	1.15e-05	0.000141	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—cervical cancer	1.08e-05	0.000132	CbGpPWpGaD
